Product Images Sildenafil
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Sildenafil NDC 51655-721 by Northwind Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 51655 721 52 Master Bottle Label Approval Rev A 06 21
This is a package of Sildenafil Citrate tablets, USP with a dosage of 20 mg. The package contains 30 tablets and is only available with a prescription. The recommended storage temperature is 20°C to 25°C. The package must be kept out of reach of children and stored in its original container, tightly closed. The tablets are repackaged by Northwind Pharmaceuticals from Mylan Pharmaceuticals Inc. The tablets are film-coated and contain sildenafil citrate equivalent to 20 mg of sildenafil. However, the text has some missing characters, making it unclear what some of the numbers refer to.*
Figure 6. Kaplan-Meier Plot of Mortality by Sildenafil Dose - image 02
This appears to be a table showing estimated cumulative mortality rates (%) over time (in years) for three different dose levels (high, medium, and low) of something. The table contains numerical values for each dose level at different time points. However, it is not clear what the substance or thing being measured in this table is.*
Sildenafil Citrate Structural Formula - image 03
Figure 7. Effects of Other Drugs on Sildenafil Pharmacokinetics - image 04
This text appears to be a chart or table showing different drugs and their recommendations for dose adjustments. The chart includes drugs such as Atorvastatin, Azithromycin, Bosentan, Cimatiding, Erythromycin, Maalox, Oral Contraceptives, Ritonavi, and Saquinavie. The chart lists whether or not dose adjustments are needed for each drug and provides information on AUC and Gmax. There is also a note regarding the recommended coadministration of Ritonavi with Sildenafil. However, without full context or clear interpretation, the information in this text can be difficult to understand.*
Figure 8. Effects of Sildenafil on Other Drugs - image 05
This is a table showing the recommended drug fold change and 90% CI for various drugs. It suggests dose adjustments or coadministration for certain drugs to ensure effective treatment. The drugs listed include Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Lovonorgestrel, Phenprocoumon, Ritonavir, Ssqunave, and Tobuamde.*
Figure 9. Change from Baseline in 6-Minute Walk Distance (meters) at Weeks 4, 8, and 12 in Study 1: Mean (95% Confidence Interval) - image 06
Figure 10. Placebo-Corrected Change from Baseline in 6-Minute Walk Distance (meters) at Week 12 by Study Subpopulation in Study 1: Mean (95% Confidence Interval) - image 07
Figure 11. Kaplan-Meier Plot of Time (in Days) to Clinical Worsening of PAH in Study 2 - image 08
Figure 12. Mean Change from Baseline in 6-Minute Walk (meters) by Visit to Week 12 – ITT Population Sildenafil Protocol A1481244 - image 09
This appears to be a table showing the change from baseline in meters for different treatments over the course of up to 12 weeks. The treatments listed are Sildenafil 1 mg TID, Sildenafil 5 mg TID, and Sildenafil 20 mg TID. The table presents the mean change from baseline and standard error for each treatment at each visit up to week 12.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.